Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Sales | 20 | 20 | 2,548 | 2,600 | 2,890 |
| Cost of Goods | N/A | N/A | 895 | 692 | 767 |
| Gross Profit | 20 | 20 | 1,653 | 1,908 | 2,123 |
| Operating Expenses | 18,397 | 11,437 | 25,497 | 31,571 | 58,881 |
| Operating Income | -18,377 | -11,417 | -22,949 | -28,971 | -55,991 |
| Interest Expense | 1,583 | 7,962 | 19,335 | 21,710 | 27,991 |
| Other Income | 1,870 | 4,323 | 4,000 | 5,060 | 25,928 |
| Pre-tax Income | -18,090 | -15,056 | -38,284 | -45,621 | -58,054 |
| Net Income Continuous | -18,090 | -15,056 | -38,284 | -45,621 | -58,054 |
| Minority Interests | -63 | -89 | -31 | -32 | -31 |
| Net Income | $-18,027 | $-14,967 | $-38,253 | $-45,589 | $-58,023 |
| EPS Basic Total Ops | -18.00 | -15.00 | 2,606.48 | -848.83 | -1,553.69 |
| EPS Basic Continuous Ops | -12.16 | -15.82 | 2,081.66 | -813.92 | -1,521.16 |
| EPS Diluted Total Ops | -18.00 | -15.00 | 2,606.48 | -848.83 | -1,553.69 |
| EPS Diluted Continuous Ops | -12.16 | -15.82 | 2,081.66 | -813.92 | -1,521.16 |
| EBITDA(a) | $-18,009 | $-10,837 | $-22,138 | $-27,594 | $-54,520 |